Previous research has shown Melittin’s anti-inflammatory actions in cases of cerebral ischemia, where it reduced the elevated cytokine levels (IL-1β, IL-6, TNF-α) post-ischemia by inhibiting the NF-κB signaling pathway linked to inflammatory factor production [18]. This evidence concerns the gene IL1B and ischemia.